Jump to main content
Jump to site search

Issue 48, 2018
Previous Article Next Article

Meroterpene-like compounds derived from β-caryophyllene as potent α-glucosidase inhibitors

Author affiliations

Abstract

Meroterpenoids isolated from guava (Psidium guajava) and Rhodomyrtus tomentosa possess special skeletons which incorporate terpenoids with phloroglucinol derivatives. Most of these meroterpenoids showed high cytotoxicity against cancer cell lines. However, their chemical diversity is very limited. Herein, we employed a biomimetic hetero-cycloaddition starting from ortho-quinone methides and an abundant natural product, β-caryophyllene, to generate meroterpene-like compounds. Considering that the source plant has hyperglycemic functions, α-glucosidase was selected as a target for bioassay. Nine compounds were screened out for promising activities (IC50 < 15 μM), which were better than the positive controls genistein and acarbose. The best inhibitor 12 (IC50 2.73 μM) possesses two caryophyllene moieties. They represented a new type of skeleton possessing activities against α-glucosidase. The kinetic study exhibited that these inhibitors belong to a non-competitive type. All these inhibitors may provide an opportunity to develop a new class of antidiabetic agents.

Graphical abstract: Meroterpene-like compounds derived from β-caryophyllene as potent α-glucosidase inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 30 Oct 2018, accepted on 26 Nov 2018 and first published on 27 Nov 2018


Article type: Paper
DOI: 10.1039/C8OB02687D
Citation: Org. Biomol. Chem., 2018,16, 9454-9460
  •   Request permissions

    Meroterpene-like compounds derived from β-caryophyllene as potent α-glucosidase inhibitors

    S. Ma, J. Yu, D. Yan, D. Wang, J. Gao and Q. Zhang, Org. Biomol. Chem., 2018, 16, 9454
    DOI: 10.1039/C8OB02687D

Search articles by author

Spotlight

Advertisements